NBC News
US · 3 hrs ago
✦ 72◉ Centre
Breakthrough pancreatic cancer treatment could double survival time
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ⚠ Misleading headline
A new study suggests that a pancreatic cancer drug called daraxonrasib may double survival rates for over 90% of patients, with researchers exploring its potential for other cancer types.
Breakthrough pancreatic cancer treatment could double survival time
A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than 90 percent of patients. Researchers are now exploring whether the drug, called daraxonrasib, could also be effective in lung, ovarian, and colorectal cancers. NBC News’ Erika Edwards reports.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!